Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hippo Holdings (HIPO) Research & Development (2020 - 2026)

Hippo Holdings filings provide 7 years of Research & Development readings, the most recent being $9.4 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 16.05% to $9.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $33.8 million, a 10.82% increase, with the full-year FY2025 number at $32.5 million, up 5.86% from a year prior.
  • Research & Development hit $9.4 million in Q1 2026 for Hippo Holdings, up from $8.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $16.5 million in Q2 2022 to a low of $7.0 million in Q3 2024.
  • Median Research & Development over the past 5 years was $9.4 million (2026), compared with a mean of $10.4 million.
  • Biggest five-year swings in Research & Development: surged 120.0% in 2022 and later tumbled 41.18% in 2024.
  • Hippo Holdings' Research & Development stood at $11.5 million in 2022, then fell by 9.57% to $10.4 million in 2023, then fell by 26.92% to $7.6 million in 2024, then grew by 9.21% to $8.3 million in 2025, then increased by 13.25% to $9.4 million in 2026.
  • The last three reported values for Research & Development were $9.4 million (Q1 2026), $8.3 million (Q4 2025), and $8.0 million (Q3 2025) per Business Quant data.